AI-based model enhances efficiency of Type II diabetes prevention efforts

Better prevention of Type II diabetes could save both lives and money. The U.S. spends over $730 billion a year -; nearly a third of all health care spending -; on treating preventable diseases like diabetes.

Truvian raises $74M to bring blood test instrument to market

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Truvian Health has raised $74

July 22, 2024

Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) – Biotech Investments

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Study results Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual

April 9, 2024

FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction

Finerenone reduced heart failure (HF) events and cardiovascular death in patients with HF and mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF), according to late-breaking

September 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.